Q4 2019 Karyopharm Therapeutics Inc Earnings Call Transcript
Good morning. My name is Cherie, and I will be your conference operator today. At this time, I would like to welcome everyone to the Karyopharm Therapeutics Fourth Quarter and Full Year 2019 Financial Results Conference Call. (Operator Instructions) Please be advised that this call is being recorded at the company's request.
I would now like to turn the call over to Mr. Ian Karp, Karyopharm's Vice President, Investor and Public Relations. Please go ahead.
Thank you, Cherie, and thank you all for joining us on today's conference call to discuss Karyopharm's Fourth Quarter and Full Year 2019 Financial Results and Business Update. This is Ian Karp, and I'm joined today by Dr. Michael Kauffman, our Chief Executive Officer; Mr. Mike Mason, Chief Financial Officer; Mr. Christopher Primiano, Chief Business Officer and General Counsel; and Mr. Perry Monaco, Senior Vice President of Sales.
On the call today, Michael will provide an overview of key recent corporate
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |